Clinical Trials Sponsored by Beth Israel Medical Center

Total 1348 results

Beth Israel Deaconess Medical Center
Ornim Medical Ltd.

Completed

UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation (UTLight)

Diabetes

United States
Beth Israel Deaconess Medical Center
MedWaves, Inc

Recruiting

Feasibility of the AveCure Microwave Ablation Technology for the Bronchoscopic Treatment of Malignant Central Airway Obstructions

Airway Obstruction | Central Airway Obstruction

United States
Beth Israel Deaconess Medical Center
Regeneron Pharmaceuticals

Recruiting

Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids

Keloid

United States
Beth Israel Deaconess Medical Center
Boston College

Recruiting

The Effect of Sleep Deprivation and Recovery Sleep on Emotional Memory and Affective Reactivity

Sleep | Sleep Deprivation

United States
Beth Israel Deaconess Medical Center
Harvard University

Recruiting

Hematoma Block for Distal Radius Fracture (Hematoma Block)

Distal Radius Fracture

United States
Beth Israel Deaconess Medical Center
Boston IVF

Completed

PooR Embryo Yield Cleavage Stage Versus blaStocyst Embryo Transfer (PILOT STUDY) (PRECiSE)

Infertility

United States
Beth Israel Deaconess Medical Center
Boston University

Active, not recruiting

Temporal Interference Brain Stimulation (TI)

Visual Acuity

United States
Beth Israel Deaconess Medical Center
Novartis Pharmaceuticals

Terminated

Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)

Necrobiosis Lipoidica Diabeticorum

United States
Hebrew SeniorLife
Beth Israel Deaconess Medical Center

Completed

The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults (SOTRUE)

Hypertension | Aging | Physical Disability

United States
Beth Israel Deaconess Medical Center
Open Philanthropy

Completed

Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial

Sepsis | Septic Shock | Metabolic Disturbance

United States
Beth Israel Deaconess Medical Center
Harvard University

Completed

Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing (APAPII)

Acetaminophen Toxicity

United States
Beth Israel Deaconess Medical Center
HydroDot, Inc.

Completed

Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings

Epilepsy | Seizures

United States
Beth Israel Deaconess Medical Center
Merz Pharmaceuticals

Withdrawn

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) (Xeomin)

Parkinson Disease | Amyotrophic Lateral Sclerosis

United States
Beth Israel Deaconess Medical Center
ALS Association

Completed

Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials

Amyotrophic Lateral Sclerosis

United States
Beth Israel Deaconess Medical Center
Dartmouth-Hitchcock Medical Center

Active, not recruiting

Treating Schizophrenia by Correcting Abnormal Brain Development

Schizophrenia

United States
Roger Williams Medical Center
Beth Israel Deaconess Medical Center

Completed

Gene Therapy in Treating Patients With Cancer

Cancer

United States
Hadassah Medical Organization
Beth Israel Deaconess Medical Center

Unknown

Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence

Pre-Eclampsia

Israel
Joslin Diabetes Center
Beth Israel Deaconess Medical Center

Completed

Effect of Dietary Fat on Glycemic Control in Type 1 Diabetes

Type 1 Diabetes

United States
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)

Completed

Discussing Stopping Cancer Screening and Prognosis With Older Adults

Cancer Screening

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Terminated

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast Cancer

United States
Beth Israel Deaconess Medical Center

Withdrawn

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Completed

In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer

Malignant Melanoma

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center

Completed

NIR-Guided Sentinel Lymph Node Mapping in Melanoma

Melanoma

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center

Completed

Exercise Intervention in Women With Metastatic Breast Cancer

Breast Cancer

United States
Beth Israel Deaconess Medical Center

Completed

Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors

Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Cavity Cancer

United States
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)

Completed

Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain

Brain and Central Nervous System Tumors | Metastatic Cancer | Melanoma (Skin)

United States
Beth Israel Deaconess Medical Center

Completed

Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma

Lymphoma

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center

Completed

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)

Completed

Trial of a Mammography Decision Aid for Women Aged 75 and Older

Breast Cancer Screening

United States
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)

Completed

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Cancer

United States
Beth Israel Deaconess Medical Center

Completed

Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Peritoneal Cavity Cancer

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Recruiting

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Prostate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

United States
Beth Israel Deaconess Medical Center

Recruiting

A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Blood Flow MRI for Monitoring Brain Tumors (Glioma)

Brain Tumors

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Active, not recruiting

A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Completed

IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma

Malignant Melanoma

United States
Beth Israel Deaconess Medical Center

Active, not recruiting

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

Breast Cancer

United States
Beth Israel Deaconess Medical Center

Terminated

Lenalidomide After Allo Transplant

Lymphoma | Multiple Myeloma

United States
Beth Israel Deaconess Medical Center

Unknown

Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma

Melanoma (Skin)

United States
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)

Unknown

Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

Breast Cancer

United States
Beth Israel Deaconess Medical Center

Completed

Boron Neutron Capture Therapy in Treating Patients With Melanoma

Melanoma (Skin)

United States
Beth Israel Deaconess Medical Center

Completed

Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Lymphoma | Leukemia

United States
Beth Israel Deaconess Medical Center

Completed

Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Beth Israel Deaconess Medical Center

Withdrawn

RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Beth Israel Medical Center
St. Luke's-Roosevelt Hospital Center

Terminated

Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma (STRONG)

Glioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Brain Tumors

United States
Beth Israel Deaconess Medical Center
Kaneka Medical America LLC

Completed

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

Cardiac Arrest

United States
Beth Israel Medical Center
St. Luke's-Roosevelt Hospital Center

Terminated

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Metastatic Pancreatic Adenocarcinoma

United States
Beth Israel Medical Center
St. Luke's-Roosevelt Hospital Center

Terminated

Neo-Adjuvant FOLFOX for Rectal Carcinoma

Rectal Neoplasms

United States
Beth Israel Medical Center
St. Luke's-Roosevelt Hospital Center

Completed

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

Paclitaxel-induced Neuropathy

United States
Beth Israel Deaconess Medical Center
Kaneka Medical America LLC

Completed

Ubiquinol (Reduced COQ10) for Patients With Sepsis

Sepsis

United States

Clinical Trials Sponsored by Beth Israel Medical Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations